ACLX
Price
$89.99
Change
-$0.35 (-0.39%)
Updated
Nov 18 closing price
Capitalization
5.2B
99 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$64.31
Change
+$0.21 (+0.33%)
Updated
Nov 18 closing price
Capitalization
4.63B
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACLX vs KYMR

Header iconACLX vs KYMR Comparison
Open Charts ACLX vs KYMRBanner chart's image
Arcellx
Price$89.99
Change-$0.35 (-0.39%)
Volume$750.82K
Capitalization5.2B
Kymera Therapeutics
Price$64.31
Change+$0.21 (+0.33%)
Volume$384.15K
Capitalization4.63B
ACLX vs KYMR Comparison Chart in %
ACLX
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACLX vs. KYMR commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (ACLX: $89.90 vs. KYMR: $64.38)
Brand notoriety: ACLX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 150% vs. KYMR: 48%
Market capitalization -- ACLX: $5.2B vs. KYMR: $4.63B
ACLX [@Biotechnology] is valued at $5.2B. KYMR’s [@Biotechnology] market capitalization is $4.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ACLX and KYMR are a good buy in the short-term.

Price Growth

ACLX (@Biotechnology) experienced а -0.37% price change this week, while KYMR (@Biotechnology) price change was +1.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was -2.53%, and the average quarterly price growth was +64.80%.

Reported Earning Dates

ACLX is expected to report earnings on Feb 26, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($5.2B) has a higher market cap than KYMR($4.63B). KYMR YTD gains are higher at: 60.017 vs. ACLX (17.225). ACLX has higher annual earnings (EBITDA): -179.78M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. ACLX (453M). ACLX has less debt than KYMR: ACLX (52.5M) vs KYMR (85.7M). ACLX has higher revenues than KYMR: ACLX (57M) vs KYMR (44.7M).
ACLXKYMRACLX / KYMR
Capitalization5.2B4.63B112%
EBITDA-179.78M-267.03M67%
Gain YTD17.22560.01729%
P/E RatioN/AN/A-
Revenue57M44.7M128%
Total Cash453M665M68%
Total Debt52.5M85.7M61%
TECHNICAL ANALYSIS
Technical Analysis
ACLXKYMR
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
78%
Bearish Trend 29 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDSX36.820.09
+0.25%
Artisan Small Cap Advisor
FSPSX60.27N/A
N/A
Fidelity International Index
RMDCX3.33N/A
N/A
Virtus Silvant Mid-Cap Growth C
BSGIX15.12N/A
N/A
Baird Small/Mid Cap Growth Institutional
TSRLX80.54N/A
N/A
Touchstone Large Cap Focused R6

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-0.49%
CGON - ACLX
56%
Loosely correlated
+3.15%
BEAM - ACLX
53%
Loosely correlated
-0.36%
NUVL - ACLX
52%
Loosely correlated
-3.48%
ROIV - ACLX
52%
Loosely correlated
-0.17%
XNCR - ACLX
52%
Loosely correlated
+2.62%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.43%
NRIX - KYMR
64%
Loosely correlated
-1.02%
VERA - KYMR
61%
Loosely correlated
-2.00%
IDYA - KYMR
54%
Loosely correlated
+1.08%
RGNX - KYMR
54%
Loosely correlated
+0.94%
NUVL - KYMR
54%
Loosely correlated
-3.48%
More